Track topics on Twitter Track topics that are important to you
Scios Inc. is a biopharmaceutical company engaged in the discovery, development, manufacture and commercialization of novel human therapeutics based upon its capabilities in both protein-based and small-molecule drug discovery and development. An NDA for the use of Natrecor(R) (nesiritide) for the short-term management of congestive heart failure ispending with the U.S. Food and Drug Administration ("FDA"). On January 29, 1999, the Cardiovascular and Renal Drugs Advisory Committee to the FDA recommended that the FDA approve Natrecor(R) for sale in the United States. Fiblast(R) (trafermin) is in Phase II/III clinical trials in Europe for stroke and the Company plans to do additional Phase II clinical trials for other vascular indications.
820 West Maude Avenue
United States of America
Phone: (408) 616-8200
Fax: 415 968 2438
LIVINGSTON, NJ --(Marketwired - September 14, 2017) - Milestone Scientific Inc. (NYSE American: MLSS) (NYSE MKT: MLSS), a medical company that develops and commercializes a growing portfolio of propri...
Dry powder inhalers (DPIs) have been among the fastest developing inhaler forms in the past decades. Researches are focusing on the formulation of carrier-free powders to obtain a higher deep-lung dep...
Many patients with exacerbations of heart failure have significant concomitant kidney dysfunction. The combination of these two conditions makes pharmacological management difficult. In th...
In 2001, Scios Inc. caught international attention with the successful U.S. launch of NATRECOR® (nesiritide), the first new approved treatment for acute heart failure in more than a decade. To date, ...
Scios Inc. is a biopharmaceutical company engaged in the discovery, development, manufacture and commercialization of novel human therapeutics based upon its capabilities in both protein-...
PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...
Guilford Pharmaceuticals Inc. was founded in July 1993 by Scios Nova Inc., Dr. Solomon H. Snyder and Dr. Craig R. Smith to discover and develop novel pharmaceutical and biopolymer-based products that ...
We have published hundreds of Scios Incorporated news stories on BioPortfolio along with dozens of Scios Incorporated Clinical Trials and PubMed Articles about Scios Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Scios Incorporated Companies in our database. You can also find out about relevant Scios Incorporated Drugs and Medications on this site too.
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...